SPHK2 and breast cancer: Of these, RFS was best predicted by SPHK2 (P < 1e-16), SGPP1 (p = 1.6e-07), and PLPP3 (LPP3; p = 1.8e-10), where patients with BC with a lower expression of these enzymes had worse RFS (Figure 1).